Glenn Sobotka - 14 Apr 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Reporting relationship: Chief Accounting Officer
Issuer ticker: AGL
Reported as of: 14 Apr 2022
Net transaction value: -$7,705
SEC form: 4/A - Amendment
Accepted by SEC: 29 Sep 2022, 16:11:47 UTC
Original report date: 20 Apr 2022
Prior SEC filing: 12 Nov 2021
Next SEC filing: 28 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Timothy Bensley, as Attorney-in-Fact

Key filing fact

Glenn Sobotka filed Form 4/A - Amendment for agilon health, inc. (AGL) on 29 Sep 2022.

Key facts

This page summarizes Glenn Sobotka's Form 4/A - Amendment filing for agilon health, inc. (AGL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Sep 2022, 16:11.

Change

Previous filing in this sequence was filed on 12 Nov 2021.
Current net transaction value: -$7,705.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGL transaction

Common Stock

Tax liability

Transaction value: $7,705
Shares: -334
Change %: -5.9%
Price: $23.07
Shares after: 5,365
Date: 14 Apr 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.

Footnote F2

Includes restricted stock units.

SEC remarks

This Form 4 Amendment reports the tax withholding pertaining to the vesting of restricted stock units, which was inadvertently omitted on the Form 4 filed on April 20, 2022.